Lyophilized peptide vials with Certificate of Analysis. The next evolution in GLP-1 receptor agonist research — sourced and delivered across Nigeria.
Mechanism of Action
The only triple-agonist targeting all three metabolic receptors simultaneously.
Reduces appetite and slows gastric emptying. The same mechanism used by semaglutide-class compounds, supported by extensive clinical literature.
Enhances insulin sensitivity and improves fat metabolism. The dual-agonist advantage shared with tirzepatide-class compounds for amplified results.
The unique third target. Increases energy expenditure and promotes fat oxidation — the mechanism that sets retatrutide apart from all other GLP-1 compounds.
Product Catalog
Each vial ships with Certificate of Analysis. For research use only.
Loading catalog...
Comparison
Understanding the differences between GLP-1 receptor agonist compounds.
| Retatrutide | Tirzepatide | Semaglutide | |
|---|---|---|---|
| Receptors | 3 (GLP-1 + GIP + GCG) | 2 (GLP-1 + GIP) | 1 (GLP-1) |
| Mechanism | Triple agonist | Dual agonist | Single agonist |
| Administration | Weekly injection | Weekly injection | Weekly injection |
| Key Advantage | Added fat oxidation via glucagon | Enhanced insulin sensitivity | Most studied, longest track record |
| Generation | 3rd Gen | 2nd Gen | 1st Gen |
Protocol
Retatrutide is administered once weekly. Protocols should be supervised by a licensed physician.
Dosing is for informational purposes only. Always follow your prescribing physician's instructions.
Certificate of Analysis available. Every batch tested for purity before dispatch.
Same-day Lagos. 2-day delivery to all other states across Nigeria.
Freeze-dried for maximum stability. Cold-chain stored under optimal conditions.
All protocols reviewed by a licensed physician. Your safety is our priority.
FAQ
Common questions about our research peptides and ordering process.